Stem cell therapy for cardiac dysfunction

SpringerPlus

Volumn 3, Issue 1, 2014, Pages

  Matar, Amer A ^a   Chong, James J H ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Cardiac regeneration; Myocardial infarction; Stem cells

Indexed keywords

EID: 84920110283     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-3-440     Document Type: Review

References (104)

1. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B: Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis.Arch Intern Med 2007,167(10):989–997. doi:10.1001/archinte.167.10.989
2. Aggarwal S, Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses.Blood 2005,105(4):1815–1822. doi:10.1182/blood-2004–04–1559
3. Andersen DC, Andersen P, Schneider M, Jensen HB, Sheikh SP: Murine “cardiospheres” are not a source of stem cells with cardiomyogenic potential.Stem Cells 2009,27(7):1571–1581. doi:10.1002/stem.72
4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis.Science 1997,275(5302):964–967.
5. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC: Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium.Nature 2004,428(6983):668–673. doi:10.1038/nature02460
6. Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El Nakadi B, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, Tendera M, Waldman S, Wijns W, Terzic A: Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.J Am Coll Cardiol 2013,61(23):2329–2338. doi:10.1016/j.jacc.2013.02.071
7. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW, Lecapitaine N, Cascapera S, Beltrami AP, D’Alessandro DA, Zias E, Quaini F, Urbanek K, Michler RE, Bolli R, Kajstura J, Leri A, Anversa P: Human cardiac stem cells.Proc Natl Acad Sci U S A 2007,104(35):14068–14073. doi:10.1073/pnas.0706760104
8. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P: Adult cardiac stem cells are multipotent and support myocardial regeneration.Cell 2003,114(6):763–776.
9. Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.Lancet 2011,378(9806):1847–1857. doi:10.1016/s0140–6736(11)61590–0
10. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y, Roberts DJ, Huang PL, Domian IJ, Chien KR: Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages.Nature 2009,460(7251):113–117. doi:10.1038/nature08191
11. Cai L, Johnstone BH, Cook TG, Tan J, Fishbein MC, Chen PS, March KL: IFATS collection: human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function.Stem Cells 2009,27(1):230–237. doi:10.1634/stemcells.2008–0273
12. Challen GA, Boles NC, Chambers SM, Goodell MA: Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1.Cell Stem Cell 2010,6(3):265–278. doi:10.1016/j.stem.2010.02.002
13. Choi WY, Poss KD: Cardiac regeneration.Curr Top Dev Biol 2012, 100:319–344. doi:10.1016/b978–0-12–387786–4.00010–5
14. Chong JJH, Murry CE: Cardiac regeneration using pluripotent stem cells–progression to large animal models.Stem Cell Res 2014. doi:10.1016/j.scr.2014.06.005
15. Chong JJ, Chandrakanthan V, Xaymardan M, Asli NS, Li J, Ahmed I, Heffernan C, Menon MK, Scarlett CJ, Rashidianfar A, Biben C, Zoellner H, Colvin EK, Pimanda JE, Biankin AV, Zhou B, Pu WT, Prall OW, Harvey RP: Adult cardiac-resident MSC-like stem cells with a proepicardial origin.Cell Stem Cell 2011,9(6):527–540. doi:10.1016/j.stem.2011.10.002
16. Chong JJ, Reinecke H, Iwata M, Torok-Storb B, Stempien-Otero A, Murry CE: Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart.Stem Cells Dev 2013,22(13):1932–1943. doi:10.1089/scd.2012.0542
17. Chong JJH, Yang X, Don CW, Minami E, Liu Y-W, Weyers JJ, Mahoney WM, Van Biber B, Cook SM, Palpant NJ, Gantz JA, Fugate JA, Muskheli V, Gough GM, Vogel KW, Astley CA, Hotchkiss CE, Baldessari A, Pabon L, Reinecke H, Gill EA, Nelson V, Kiem H-P, Laflamme MA, Murry CE: Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.Nature 2014,510(7504):273–277. doi:10.1038/nature13233. http://www.nature.com/nature/journal/v510/n7504/abs/nature13233.html#supplementary-information
18. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, Pappas P, Tatooles A, Stoddard MF, Lima JA, Slaughter MS, Anversa P, Bolli R: Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance.Circulation 2012,126(11 Suppl 1):S54–64. doi:10.1161/circulationaha.112.092627
19. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Clarke MJ, Watt SM, Martin-Rendon E: Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes.PLoS One 2012,7(5):e37373. doi:10.1371/journal.pone.0037373
20. da Silva Meirelles L, Chagastelles PC, Nardi NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues.J Cell Sci 2006,119(Pt 11):2204–2213. doi:10.1242/jcs.02932
21. Davis DR, Zhang Y, Smith RR, Cheng K, Terrovitis J, Malliaras K, Li TS, White A, Makkar R, Marban E: Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue.PLoS One 2009,4(9):e7195. doi:10.1371/journal.pone.0007195
22. Davis DR, Ruckdeschel Smith R, Marban E: Human cardiospheres are a source of stem cells with cardiomyogenic potential.Stem Cells 2010,28(5):903–904. doi:10.1002/stem.413
23. Dey D, Han L, Bauer M, Sanada F, Oikonomopoulos A, Hosoda T, Unno K, De Almeida P, Leri A, Wu JC: Dissecting the molecular relationship among various cardiogenic progenitor cells.Circ Res 2013,112(9):1253–1262. doi:10.1161/circresaha.112.300779
24. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM: Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.Blood 2002,99(10):3838–3843.
25. Eckfeldt CE, Mendenhall EM, Verfaillie CM: The molecular repertoire of the ‘almighty’ stem cell.Nat Rev Mol Cell Biol 2005,6(9):726–737. doi:10.1038/nrm1713
26. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK: Cardioprotective c-kit + cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.J Clin Invest 2006,116(7):1865–1877. doi:10.1172/jci27019
27. Fernandes S, Naumova AV, Zhu WZ, Laflamme MA, Gold J, Murry CE: Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats.J Mol Cell Cardiol 2010,49(6):941–949. doi:10.1016/j.yjmcc.2010.09.008
28. Friedenstein AJ, Chailakhjan RK, Lalykina KS: The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells.Cell Tissue Kinet 1970,3(4):393–403.
29. Friis T, Haack-Sorensen M, Mathiasen AB, Ripa RS, Kristoffersen US, Jorgensen E, Hansen L, Bindslev L, Kjaer A, Hesse B, Dickmeiss E, Kastrup J: Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina.Scand Cardiovasc J 2011,45(3):161–168. doi:10.3109/14017431.2011.569571
30. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W: A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.J Am Coll Cardiol 2009,54(24):2277–2286. doi:10.1016/j.jacc.2009.06.055
31. Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, George R, Lardo A: Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.JAMA 2012,308(22):2369–2379. doi:10.1001/jama.2012.25321
32. Heldman AW, DiFede DL, Fishman JE, Zambrano JP, Trachtenberg BH, Karantalis V, Mushtaq M, Williams AR, Suncion VY, McNiece IK, Ghersin E, Soto V, Lopera G, Miki R, Willens H, Hendel R, Mitrani R, Pattany P, Feigenbaum G, Oskouei B, Byrnes J, Lowery MH, Sierra J, Pujol MV, Delgado C, Gonzalez PJ, Rodriguez JE, Bagno LL, Rouy D, Altman P, et al.: Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.JAMA 2014,311(1):62–73. doi:10.1001/jama.2013.282909
33. Hierlihy AM, Seale P, Lobe CG, Rudnicki MA, Megeney LA: The post-natal heart contains a myocardial stem cell population.FEBS Lett 2002,530(1–3):239–243.
34. Holmes C, Stanford WL: Concise review: stem cell antigen-1: expression, function, and enigma.Stem Cells 2007,25(6):1339–1347. doi:10.1634/stemcells.2006–0644
35. Johnston PV, Sasano T, Mills K, Evers R, Lee ST, Smith RR, Lardo AC, Lai S, Steenbergen C, Gerstenblith G, Lange R, Marban E: Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy.Circulation 2009,120(12):1075–1083. 1077 p following 1083. doi:10.1161/circulationaha.108.816058
36. Karantalis V, DiFede DL, Gerstenblith G, Pham S, Symes J, Zambrano JP, Fishman J, Pattany P, McNiece I, Conte J, Schulman S, Wu K, Shah A, Breton E, Davis-Sproul J, Schwarz R, Feigenbaum G, Mushtaq M, Suncion VY, Lardo AC, Borrello I, Mendizabal A, Karas TZ, Byrnes J, Lowery M, Heldman AW, Hare JM: Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.Circ Res 2014,114(8):1302–1310. doi:10.1161/circresaha.114.303180
37. Klaus A, Muller M, Schulz H, Saga Y, Martin JF, Birchmeier W: Wnt/beta-catenin and Bmp signals control distinct sets of transcription factors in cardiac progenitor cells.Proc Natl Acad Sci U S A 2012,109(27):10921–10926. doi:10.1073/pnas.1121236109
38. Laflamme MA, Murry CE: Heart regeneration.Nature 2011,473(7347):326–335. doi:10.1038/nature10147
39. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O’Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE: Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.Nat Biotechnol 2007,25(9):1015–1024. doi:10.1038/nbt1327
40. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu MM, Reth M, Platoshyn O, Yuan JX, Evans S, Chien KR: Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages.Nature 2005,433(7026):647–653. doi:10.1038/nature03215
41. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S: Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host.Proc Natl Acad Sci U S A 2003,100(13):7808–7811. doi:10.1073/pnas.1232447100
42. Leri A, Kajstura J, Anversa P: Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology.Circ Res 2011,109(8):941–961. doi:10.1161/circresaha.111.243154
43. Li X, Yu X, Lin Q, Deng C, Shan Z, Yang M, Lin S: Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment.J Mol Cell Cardiol 2007,42(2):295–303. doi:10.1016/j.yjmcc.2006.07.002
44. Li H, Zuo S, He Z, Yang Y, Pasha Z, Wang Y, Xu M: Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival.Am J Physiol Heart Circ Physiol 2010,299(6):H1772–1781. doi:10.1152/ajpheart.00557.2010
45. Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita N, Blusztajn A, Terrovitis J, Kusuoka H, Marban L, Marban E: Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.J Am Coll Cardiol 2012,59(10):942–953. doi:10.1016/j.jacc.2011.11.029
46. Linke A, Muller P, Nurzynska D, Casarsa C, Torella D, Nascimbene A, Castaldo C, Cascapera S, Bohm M, Quaini F, Urbanek K, Leri A, Hintze TH, Kajstura J, Anversa P: Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function.Proc Natl Acad Sci U S A 2005,102(25):8966–8971. doi:10.1073/pnas.0502678102
47. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marban L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marban E: Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.Lancet 2012,379(9819):895–904. doi:10.1016/s0140–6736(12)60195–0
48. Malliaras K, Li TS, Luthringer D, Terrovitis J, Cheng K, Chakravarty T, Galang G, Zhang Y, Schoenhoff F, Van Eyk J, Marban L, Marban E: Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells.Circulation 2012,125(1):100–112. doi:10.1161/circulationaha.111.042598
49. Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, Bates S, Goetsch SC, Gallardo TD, Garry DJ: Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart.Dev Biol 2004,265(1):262–275.
50. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM: Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.Eur Heart J 2008,29(15):1807–1818. doi:10.1093/eurheartj/ehn220
51. Matsuura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H, Sano M, Toko H, Akazawa H, Sato T, Nakaya H, Kasanuki H, Komuro I: Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes.J Biol Chem 2004,279(12):11384–11391. doi:10.1074/jbc.M310822200
52. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, Duboc D: Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.J Am Coll Cardiol 2003,41(7):1078–1083.
53. Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagege AA: The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.Circulation 2008,117(9):1189–1200. doi:10.1161/circulationaha.107.734103
54. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, Salio M, Battaglia M, Latronico MV, Coletta M, Vivarelli E, Frati L, Cossu G, Giacomello A: Isolation and expansion of adult cardiac stem cells from human and murine heart.Circ Res 2004,95(9):911–921. doi:10.1161/01.res.0000147315.71699.51
55. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H: Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.Circulation 2006,113(10):1287–1294. doi:10.1161/circulationaha.105.575118
56. Min JY, Yang Y, Converso KL, Liu L, Huang Q, Morgan JP, Xiao YF: Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats.J Appl Physiol 2002,92(1):288–296.
57. Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y, Qyang Y, Bu L, Sasaki M, Martin-Puig S, Sun Y, Evans SM, Laugwitz KL, Chien KR: Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification.Cell 2006,127(6):1151–1165. doi:10.1016/j.cell.2006.10.029
58. Mouquet F, Pfister O, Jain M, Oikonomopoulos A, Ngoy S, Summer R, Fine A, Liao R: Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells.Circ Res 2005,97(11):1090–1092. doi:10.1161/01.RES.0000194330.66545.f5
59. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.Nature 2004,428(6983):664–668. doi:10.1038/nature02446
60. Nadal-Ginard B, Kajstura J, Leri A, Anversa P: Myocyte death, growth, and regeneration in cardiac hypertrophy and failure.Circ Res 2003,92(2):139–150.
61. Nowbar AN, Mielewczik M, Karavassilis M, Dehbi H-M, Shun-Shin MJ, Jones S, Howard JP, Cole GD, Francis DP: Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. 2014., 348: doi:10.1136/bmj.g2688
62. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, Schneider MD: Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction.Proc Natl Acad Sci U S A 2003,100(21):12313–12318. doi:10.1073/pnas.2132126100
63. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Bone marrow cells regenerate infarcted myocardium.Nature 2001,410(6829):701–705. doi:10.1038/35070587
64. Orn S, Manhenke C, Anand IS, Squire I, Nagel E, Edvardsen T, Dickstein K: Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction.Am J Cardiol 2007,99(8):1109–1114. doi:10.1016/j.amjcard.2006.11.059
65. Pearl JI, Lee AS, Leveson-Gower DB, Sun N, Ghosh Z, Lan F, Ransohoff J, Negrin RS, Davis MM, Wu JC: Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.Cell Stem Cell 2011,8(3):309–317. doi:10.1016/j.stem.2011.01.012
66. Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, et al.: Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.JAMA 2012,307(16):1717–1726. doi:10.1001/jama.2012.418
67. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, Anversa P: Chimerism of the transplanted heart.N Engl J Med 2002,346(1):5–15. doi:10.1056/NEJMoa012081
68. Rangappa S, Entwistle JW, Wechsler AS, Kresh JY: Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype.J Thorac Cardiovasc Surg 2003,126(1):124–132.
69. Rasmussen TL, Raveendran G, Zhang J, Garry DJ: Getting to the heart of myocardial stem cells and cell therapy.Circulation 2011,123(16):1771–1779. doi:10.1161/circulationaha.109.858019
70. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breitbach M, Doran R, Becher UM, Hwang SM, Bostani T, von Maltzahn J, Hofmann A, Reining S, Eiberger B, Gabris B, Pfeifer A, Welz A, Willecke K, Salama G, Schrickel JW, Kotlikoff MI, Fleischmann BK: Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia.Nature 2007,450(7171):819–824. doi:10.1038/nature06321
71. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, et al.: Heart disease and stroke statistics–2011 update: a report from the American Heart Association.Circulation 2011,123(4):e18-e209. doi:10.1161/CIR.0b013e3182009701
72. Rosamond WD, Chambless LE, Heiss G, Mosley TH, Coresh J, Whitsel E, Wagenknecht L, Ni H, Folsom AR: Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987–2008.Circulation 2012,125(15):1848–1857. doi:10.1161/circulationaha.111.047480
73. Rose RA, Jiang H, Wang X, Helke S, Tsoporis JN, Gong N, Keating SC, Parker TG, Backx PH, Keating A: Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.Stem Cells 2008,26(11):2884–2892. doi:10.1634/stemcells.2008–0329
74. Ruger BM, Breuss J, Hollemann D, Yanagida G, Fischer MB, Mosberger I, Chott A, Lang I, Davis PF, Hocker P, Dettke M: Vascular morphogenesis by adult bone marrow progenitor cells in three-dimensional fibrin matrices.Differentiation 2008,76(7):772–783. doi:10.1111/j.1432–0436.2007.00259.x
75. Schuleri KH, Feigenbaum GS, Centola M, Weiss ES, Zimmet JM, Turney J, Kellner J, Zviman MM, Hatzistergos KE, Detrick B, Conte JV, McNiece I, Steenbergen C, Lardo AC, Hare JM: Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy.Eur Heart J 2009,30(22):2722–2732. doi:10.1093/eurheartj/ehp265
76. Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R: Embryonic stem cell trials for macular degeneration: a preliminary report.Lancet 2012,379(9817):713–720. doi:10.1016/s0140–6736(12)60028–2
77. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ: Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects.Ann Thorac Surg 2002,73(6):1919–1925. discussion 1926
78. Sheng CC, Zhou L, Hao J: Current stem cell delivery methods for myocardial repair.Biomed Res Int 2013, 2013:547902. doi:10.1155/2013/547902
79. Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, Chien KR, Riley PR: Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.Nature 2007,445(7124):177–182. doi:10.1038/nature05383
80. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, Giacomello A, Abraham MR, Marban E: Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.Circulation 2007,115(7):896–908. doi:10.1161/circulationaha.106.655209
81. Strauer BE, Brehm M, Zeus T, Gattermann N, Hernandez A, Sorg RV, Kogler G, Wernet P: [Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction].Dtsch Med Wochenschr 2001,126(34–35):932–938. doi:10.1055/s-2001–16579–2
82. Suncion VY, Ghersin E, Fishman JE, Zambrano JP, Karantalis V, Mandel N, Nelson KH, Gerstenblith G, DiFede Velazquez DL, Breton E, Sitammagari K, Schulman IH, Taldone SN, Williams AR, Sanina C, Johnston PV, Brinker J, Altman P, Mushtaq M, Trachtenberg B, Mendizabal AM, Tracy M, Da Silva J, McNiece IK, Lardo AC, George RT, Hare JM, Heldman AW: Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: an analysis from the percutaneous stem cell injection delivery effects on neomyogenesis (POSEIDON) randomized trial.Circ Res 2014,114(8):1292–1301. doi:10.1161/circresaha.114.302854
83. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell 2006,126(4):663–676. doi:10.1016/j.cell.2006.07.024
84. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Cell 2007,131(5):861–872. doi:10.1016/j.cell.2007.11.019
85. Tateishi K, Ashihara E, Takehara N, Nomura T, Honsho S, Nakagami T, Morikawa S, Takahashi T, Ueyama T, Matsubara H, Oh H: Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration.J Cell Sci 2007,120(Pt 10):1791–1800. doi:10.1242/jcs.006122
86. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE: Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.Nat Med 1998,4(8):929–933.
87. The Lancet Editors: Expression of concern: the SCIPIO trial.Lancet 2014,383(9925):1279. doi:10.1016/S0140–6736(14)60608–5
88. Unno K, Jain M, Liao R: Cardiac side population cells: moving toward the center stage in cardiac regeneration.Circ Res 2012,110(10):1355–1363. doi:10.1161/circresaha.111.243014
89. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, De Angelis A, Hosoda T, Chimenti S, Baker M, Limana F, Nurzynska D, Torella D, Rotatori F, Rastaldo R, Musso E, Quaini F, Leri A, Kajstura J, Anversa P: Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival.Circ Res 2005,97(7):663–673. doi:10.1161/01.res.0000183733.53101.11
90. Valina C, Pinkernell K, Song YH, Bai X, Sadat S, Campeau RJ, Le Jemtel TH, Alt E: Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction.Eur Heart J 2007,28(21):2667–2677. doi:10.1093/eurheartj/ehm426
91. van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin S-CJ, Middleton RC, Marban E, Molkentin JD: c-kit + cells minimally contribute cardiomyocytes to the heart.Nature 2014,509(7500):337–341. doi:10.1038/nature13309. http://www.nature.com/nature/journal/v509/n7500/abs/nature13309.html#supplementary-information
92. van Tuyn J, Atsma DE, Winter EM, van der Velde-van DI, Pijnappels DA, Bax NA, Knaan-Shanzer S, Gittenberger-de Groot AC, Poelmann RE, van der Laarse A, van der Wall EE, Schalij MJ, de Vries AA: Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro.Stem Cells 2007,25(2):271–278. doi:10.1634/stemcells.2006–0366
93. Veltman CE, Soliman OI, Geleijnse ML, Vletter WB, Smits PC, ten Cate FJ, Jordaens LJ, Balk AH, Serruys PW, Boersma E, van Domburg RT, van der Giessen WJ: Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy.Eur Heart J 2008,29(11):1386–1396. doi:10.1093/eurheartj/ehn171
94. Vrtovec B, Poglajen G, Lezaic L, Sever M, Socan A, Domanovic D, Cernelc P, Torre-Amione G, Haddad F, Wu JC: Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy.Circulation 2013,128(11 Suppl 1):S42–49. doi:10.1161/CIRCULATIONAHA.112.000230
95. Wakitani S, Saito T, Caplan AI: Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine.Muscle Nerve 1995,18(12):1417–1426. doi:10.1002/mus.880181212
96. Wang X, Hu Q, Nakamura Y, Lee J, Zhang G, From AH, Zhang J: The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling.Stem Cells 2006,24(7):1779–1788. doi:10.1634/stemcells.2005–0386
97. Wessels A, Perez-Pomares JM: The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells.Anat Rec A: Discov Mol Cell Evol Biol 2004,276(1):43–57. doi:10.1002/ar.a.10129
98. White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA: Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).Circulation 2005,112(22):3391–3399. doi:10.1161/circulationaha.105.551143
99. Williams AR, Trachtenberg B, Velazquez DL, McNiece I, Altman P, Rouy D, Mendizabal AM, Pattany PM, Lopera GA, Fishman J, Zambrano JP, Heldman AW, Hare JM: Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling.Circ Res 2011,108(7):792–796. doi:10.1161/circresaha.111.242610
100. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM: Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.Circulation 2013,127(2):213–223. doi:10.1161/circulationaha.112.131110
101. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW: AC133, a novel marker for human hematopoietic stem and progenitor cells.Blood 1997,90(12):5002–5012.
102. Zaruba MM, Soonpaa M, Reuter S, Field LJ: Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts.Circulation 2010,121(18):1992–2000. doi:10.1161/circulationaha.109.909093
103. Zhao T, Zhang ZN, Rong Z, Xu Y: Immunogenicity of induced pluripotent stem cells.Nature 2011,474(7350):212–215. doi:10.1038/nature10135
104. Zhou B, Honor LB, He H, Ma Q, Oh JH, Butterfield C, Lin RZ, Melero-Martin JM, Dolmatova E, Duffy HS, Gise A, Zhou P, Hu YW, Wang G, Zhang B, Wang L, Hall JL, Moses MA, McGowan FX, Pu WT: Adult mouse epicardium modulates myocardial injury by secreting paracrine factors.J Clin Invest 2011,121(5):1894–1904. doi:10.1172/jci45529